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Effects of gender and genotype on the phenotypic expression tensin II. This sodium-mediated modulation is defective
of nonmodulating essential hypertension. Nonmodulation de- in some patients with essential hypertension: thus the
scribes a subset of the normal/high renin essential hypertensive term nonmodulator. The nonmodulating characteristic ispopulation. It is an inherited trait. This report reviews the
inherited. Therefore, this trait identifies an intermediategenetic and gender data recently available that discuss the
phenotype of hypertension [4]. Two approaches distin-modification of the expression of the nonmodulating pheno-
type. Both the adrenal and the renal blood flow markers for guish the nonmodulator from the rest of the essential
nonmodulation are associated with a single nucleotide poly- hypertensive population: (1) the measurement of the
morphism (SNP) in the coding region of the angiotensinogen renal blood flow response to angiotensin II on a high-
gene at codon 235. Even though the nonmodulating phenotype
salt diet or (2) the measurement of the aldosterone re-is associated with a somatic gene, gender modifies its expres-
sponse to angiotensin II on a low-salt diet. Importantly,sion. In women, the expression of the nonmodulating pheno-
type is approximately half of that in men. Additional analysis dietary sodium intake must be fixed. Without this critical
suggests that this gender difference is almost entirely explained control of sodium intake, it is impossible to determine
by a difference in the frequency of nonmodulation in younger who is a nonmodulator.
premenopausal women. In older, likely postmenopausal women,
There are several intriguing aspects of the nonmodu-there is no gender difference. This suggests that the expression
lating hypertensive subgroup that have been reportedof the nonmodulating phenotype, presumably secondary to
over the past decade. Perhaps the most exciting havechanges in the expression of the angiotensinogen gene, is modu-
lated by female sex hormones. been those documenting an association of the nonmodu-
lating phenotype with variance in the angiotensinogen
gene [5] and the intriguing influence of gender on the
Hypertension is a common complex genetic disorder, phenotypic expression of the nonmodulating trait [6].
with genetic heritability being approximately 30% [1]. These features are reviewed in this report.
Like other multifactorial traits, hypertension is caused
by the interaction of several risk genes and a number of
METHODS
environmental factors. Because this is a complex rela-
The data reported herein come from previously pub-tionship, some have suggested that the appropriate ap-
lished reports [5, 6]. Two groups of subjects have beenproach in identifying genes involved in hypertension is
evaluated. In the first group, 120 normotensive and hy-first to identify intermediate phenotypes in the hyperten-
pertensive patients were studied [5], and of these, 34sive population [2]. With this information, a more homo-
were hypertensive. In this study, all subjects were main-geneous hypertension population could be identified that
tained on a 200 mmol sodium intake. After balance waswould allow for easier linkage to specific genes. Fifteen
achieved on the diet, the patients were admitted to ayears ago, one such intermediate phenotype was first
general clinical research center. After an overnight fastdescribed: nonmodulators [3]. In normal individuals, so-
and maintaining strict bed rest after midnight, a catheterdium intake modifies target tissue responsive to angio-
was placed intravenously in each arm at least two hours
before beginning the infusions. From one catheter, blood
samples were obtained, and through the other, para-Key words: sex hormones, blood pressure, essential hypertension,
angiotensinogen gene, phenotype for hypertension. aminohippuric acid (PAH) was infused at a rate of 719
mg/h so as to achieve a PAH plasma concentration ofÓ 2000 by the International Society of Nephrology
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approximately 2 mg/dL after a loading dose of 8 mg/kg. RESULTS
Plasma samples were obtained 10 minutes apart after a Study 1
one-hour infusion and again one hour after the beginning
The results in study 1 have been previously reportedof an angiotensin II infusion at the rate of 3 ng/kg/min. In
[5]. There is no significant relationship between angio-each subject, DNA was obtained from stored leukocytes.
tensinogen genotype and a variety of demographic char-Oligonucleotide-specific hybridization was performed
acteristics, including blood pressure. Angiotensin II infu-following enzymatic amplification of genomic DNA [7].
sion caused a small but significant increase in systolicPolymerase chain reactions were performed with oligo-
and diastolic blood pressure (9.8 6 11.2/7.9 6 8.7 mm Hg,specific probes in order to identify single nucleotide poly-
P , 0.0001). An assessment of the correlation betweenmorphisms (SNPs) at the angiotensinogen 235 codon.
angiotensinogen genotype and hemodynamic factors re-Subjects homozygote at this site for the methionine are
vealed only one significant difference: renal plasma flowreferred to as MM homozygous. Those who are homozy-
in response to angiotensin II infusion. The TT homozy-gous for threonine are referred to as mutant or TT homo-
gotes had a significantly blunted response compared withzygotes. The heterozygotes are referred to as MT.
the MT (P 5 0.001) or the MM and MT combined (P 5The second study comprised 235 individuals with es-
0.008). While there is no significant relationship betweensential hypertension who ranged in age from 18 to 71
genotype and unadjusted renal plasma flow, when renalyears old [6]. Antihypertensive medicine was discon-
plasma flow was adjusted for age, sex, body mass index,tinued at least two weeks before beginning the protocol.
and baseline renal plasma flow and the presence of hy-For those subjects taking angiotensin-converting enzyme
pertension, a significant genotype effect was observed(ACE) inhibitors, the medication was discontinued for
(partial r 2 0.038, F 5 8.1, P 5 0.005). Using these adjust-three months. When admitted to the general clinical
ments, renal plasma flow response to angiotensin II wasresearch center, each subject was placed on a constant
reanalyzed. Either in all subjects or only in the normoten-isocaloric diet containing 10 mmol of sodium, 100 mmol
sive individuals, there was no significant difference inof potassium, and 200 mL of water per day. Twenty-
the decrement in renal plasma flow in response to angio-four–hour urine sodium measurements were used to
tensin II between subjects who were homozygous for thecheck for compliance with the low-salt diet. After four
M allele and those who were heterozygotes. In contrast,to seven days when sodium balance had been achieved
subjects who were homozygotes for the T allele had aand after an overnight fast, the subjects were infused
significantly reduced decrement (100 6 10 vs. 130 6 8 andwith 3 ng/kg/min angiotensin II for 30 minutes, similar
129 6 7 mL/min; P , 0.001 to 0.005). This relationshipto that performed in the subjects enrolled in the first
persisted even when the hypertensive subjects were ex-protocol. Plasma aldosterone levels were determined be-
cluded.fore and at the end of the angiotensin II infusion. In
Additional analyses documented that the body masseach of these subjects, the plasma renin activity response
index significantly modified renal plasma flow; however,to upright posture was also determined following 60 to
its effect varied by genotype. The regression relationship120 minutes of ambulation.
between renal plasma flow and body mass index wasThe plasma aldosterone, plasma renin activity, and
significantly more shallow in those individuals who werePAH were determined by standard techniques, as pre-
homozygous for the T allele (R 5 20.38 vs. R 5 20.61,viously described [8, 9].
respectively). Finally, the effect of gender on renal
Statistical analysis plasma flow response to angiotensin II with variation in
genotype was assessed. While the interaction betweenAnalyses were performed using SAS or SPSS com-
sex and homozygosity for the T allele did not reachputer software. Analyses included Student’s t-test, Pear-
statistical significance, females with the TT genotype hadson’s correlation, and analysis of covariance. In the sec-
decrements in renal plasma flow that were identical toond study, subjects were classified as modulators or
those observed in the other two genotypes. In contrast,nonmodulators by previously defined criteria: Nonmod-
in males, the renal plasma flow was significantly reducedulators had an increment in aldosterone in response to
if they were homozygous for the T allele (P 5 0.002).the 3 ng infusion of angiotensin II of 15 ng/dL or less
Thus, females appear to have a greater renal plasma flowand had a normal or elevated plasma renin activity on
response to angiotensin II than did the males if theythe low-salt diet. Sex differences in the frequency of
were homozygous for the T allele.modulation status were evaluated by the two-tailed Fish-
er’s exact test. Logistic regression was used to determine
Study 2which of several factors influenced nonmodulation sta-
The results reported below from study 2 have beentus, determined as a dichotomous variable. Group means
previously published [6]. There were no significant differ-are provided with the standard error as the index of
dispersion. The a level was 0.05 or less. ences between men and women in relationship to a num-
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ber of demographic characteristics, except those that renal blood flow as the characteristic of nonmodulation,
those individuals possessing the angiotensin genotypewould be anticipated; that is, the males had higher serum
and urine creatinine values. Specifically, there were simi- have a lower renal blood flow response to angiotensin II,
which is a characteristic of nonmodulation. Second, gen-lar distributions of age, body mass index, admission
blood pressure, serum potassium, and urine sodium lev- der plays a significant role in the expression of the non-
modulation phenotype. Whether using renal blood flowels. Even though demographic characteristics were simi-
lar in males and females, the frequency of nonmodula- or aldosterone responses to angiotensin II, females are
much less likely to have the nonmodulation characteris-tion as a phenotype was significantly different: The
frequency in females was 26%, and in males, it was 49% tic than males. Intriguingly, in older females (presumably
postmenopausal), the gender difference in frequency of(P 5 0.001). Differences in male versus female respon-
siveness to angiotensin II could be demonstrated even nonmodulation disappears.
There are several caveats derived from these studies.if the increment in aldosterone was assessed as a continu-
ous trait either by angiotensin II infusion (P 5 0.003) The prevalence of hypertension under the age of 50 in
women is much less than in men, whereas in older sub-or upright posture (P 5 0.01). These differences could
not be explained by differences in cortisol, potassium, jects the frequencies are similar. The results of the studies
reviewed herein suggest that one major mechanism toor plasma renin activity levels.
However, age had a significant effect on the frequency explain this gender/age effect could be the reduced fre-
quency of the expression of the nonmodulating pheno-of nonmodulation in males versus females. In the youn-
gest group (,35 years of age), only 7% of females were type in premenopausal women. Support for this is the
nearly sixfold difference in the frequency of nonmodula-nonmodulators, while 40% of males were nonmodulators.
In contrast, in those subjects over 55 years of age, 47% tion between women and men under the age of 35. This
difference approximates the differences in the overallof females were nonmodulators, while 58% of males were
nonmodulators. Furthermore, even though age had a mod- hypertensive population. Estrogen is one of the main
stimuli for the production of angiotensinogen. There areest effect on the frequency of nonmodulation in males,
at least two, if not three, estrogen response elements ongender had a more substantial effect on adrenal respon-
the regulatory region of the angiotensinogen gene. Onesiveness whether the frequency of nonmodulation was
of these is located in the 26 to 220 region, a regionexamined by logistic regression or aldosterone responses
in which there is a polymorphic marker in completeby correlation analysis. Intriguingly, of the six women
disequilibrium with the 235 MT locus of the angioten-taking estrogen-containing compounds, three of them
sinogen gene [16]. Thus, estrogen may modify the defectwere among the highest responders to angiotensin II.
in the regulatory region of the angiotensinogen gene,
which could explain the nonmodulating defect.
DISCUSSION Finally, these results suggest a specific molecular mecha-
Nonmodulation has been defined as an intermediate nism by which estrogen replacement therapy could bene-
phenotype for hypertension with the following character- fit some women who are predisposed to develop hyper-
istics: It describes a subset of the normal/high renin salt- tension. Further clarification of the relationship between
sensitive group and comprises approximately 25% of the gender and the genes of the renin-angiotensin system
total hypertensive population; the pathogenesis is likely may expand the therapeutic options for postmenopausal
to reside in a defect in the regulation of angiotensin II women.
generation at the tissue level; and angiotensin-converting
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